Molecule Details
| InChIKey | YGACXVRLDHEXKY-WXRXAMBDSA-N |
|---|---|
| Canonical SMILES | O[C@H](C[C@H]1c2c(F)cccc2-c2cncn21)[C@H]1CC[C@H](O)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.08 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB15439 |
|---|---|
| Drug Name | Navoximod |
| CAS Number | 1402837-78-8 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Navoximod is under investigation in clinical trial NCT02048709 (Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors). |
Categories: Heterocyclic Compounds, Fused-Ring
Cross-references: CHEMBL3989951 ChemSpider: 35308361 PDB: LKP